Boosting appetite in geriatric patientsOctober 25, 2026Treating the underlying driver, rather than the loss of appetite in isolation, is what separates a pet that merely survives longer from one that genuinely enjoys the time it has left.
Education Center - SponsoredVector-Borne Disease Coming to a Neighborhood Near You: Which Tests to Reach For, and Why?by • AntechWhether it’s a screening to identify exposure to tick-borne pathogens, or a broad molecular diagnostic panel to help with acute disease detection or confirm the presence of genetic material, these options empower veterinary teams, guide treatment, and support antimicrobial stewardship.
OA pain management: How three vets treated their own dogsSeptember 8, 2026Promising results from recent research are being replicated in real-world veterinary practice and are highlighted in the following case studies by veterinary specialists who use the same approach in their practices and with their own pets.
A look at ketamine as a palliative care toolAugust 31, 2026When used thoughtfully, ketamine may be a powerful tool in veterinary hospice and palliative care, allowing clinicians to re-establish comfort, reassess patient baseline, and recalibrate daily pain management strategies with greater accuracy.
VPN Plus+ ExclusiveHave You Tried This Yet? New (or New-ish) Products, Protocols and Procedures in Veterinary Anesthesia and AnalgesiaAugust 28, 2026
Palliative approaches to chronic painJuly 10, 2026Palliative care is delivered with realistic expectations, grounded in honest conversation with caregivers, and oriented toward daily living rather than curative endpoints.
A look at some easy-to-add rehabilitation tools for your clinicJune 12, 2026Incorporating physical rehabilitation into primary care practice provides an important strategy to expand services, enhance job satisfaction, and add value for clients and patients.
FDA conditionally approves drug for canine neuropathic painMay 13, 2026Liavium-CA1 is indicated for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs. The drug, with the active ingredient pregabalin, reduces the release of neurotransmitters that send pain signals in the spinal cord.
